Skip to main content
. 2019 Oct 31;10:1164. doi: 10.3389/fneur.2019.01164

Table 2.

Comparison of baseline characteristics between HE (>12.5 mL or 33%) and non-HE groups in the original cohort.

Characteristics Non-HE (n = 884) HE (n = 182) P-value
Age 61.6 ± 12.6 60.7 ± 12.9 0.354
Male sex 559 (63.2) 140 (76.9) <0.001*
Hypertension 710 (80.3) 130 (71.4) 0.008*
Diabetes mellitus 98 (11.1) 21 (11.5) 0.897
Current or previous smoking 252 (28.5) 49 (26.9) 0.718
Current or previous drinking 242 (27.4) 59 (32.4) 0.169
History of coronary heart disease 12 (1.4) 1 (0.5) 0.366
History of cerebral infarction 33 (3.7) 6 (3.3) 0.775
History of cerebral hemorrhage 30 (3.4) 15 (8.3) 0.003*
Glasgow coma scale score 14 (10–15) 12 (8–15) <0.001*
International normalized ratio 0.99 (0.94–1.04) 0.99 (0.94–1.05) 0.385
Glucose level, mmol/L 7.0 (6.1–8.6) 6.9 (6.0–8.2) 0.275
Platelet count, 103 cells/μL 203 (168–243) 201 (149–239) 0.134
Time from onset to initial CT, h 3.0 (2.0–4.5) 2.5 (1.5–3.5) <0.001*
Location of ICH 0.243
Lobe 81 (9.2) 11 (6.0)
Deep 744 (84.2) 162 (89.0)
Infratentorial 59 (6.7) 9 (4.9)
Baseline ICH volume, mL 17.1 (9.4–28.3) 21.3 (12.6–30.6) 0.012*
Intraventricular extension 312 (35.3) 72 (39.6) 0.275

ICH, intracerebral hemorrhage; HE, hematoma expansion; CT, computed tomography; SD, standard deviation; IQR, interquartile range.

*

Significant at P < 0.05.